ICAD INC. - COMMON STOCK

iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5

22 Jul 2021 16:01:00 By Nasdaq GlobeNewswire

iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval

14 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

iCAD Signs Global Distribution Agreement with Sectra

08 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

iCAD to Participate in Upcoming Virtual Investor Conferences

17 May 2021 16:05:01 By Nasdaq GlobeNewswire

iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25

17 May 2021 08:00:02 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for First Quarter Ended March 31, 2021

28 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28

20 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow

19 Apr 2021 08:00:01 By Nasdaq GlobeNewswire

iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition

05 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates

31 Mar 2021 08:00:01 By Nasdaq GlobeNewswire

iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography

15 Mar 2021 18:04:42 By Nasdaq GlobeNewswire

New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting

08 Mar 2021 12:36:23 By Nasdaq GlobeNewswire

iCAD to Participate in the Cowen 41st Annual Health Care Conference

03 Mar 2021 21:16:22 By Nasdaq GlobeNewswire

iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock

03 Mar 2021 00:47:48 By Nasdaq GlobeNewswire

iCAD Announces Proposed Public Offering of Common Stock

02 Mar 2021 16:01:00 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2020

24 Feb 2021 16:01:01 By Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24

18 Feb 2021 18:56:26 By Nasdaq GlobeNewswire

iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

16 Feb 2021 16:01:00 By Nasdaq GlobeNewswire

iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference

19 Jan 2021 08:00:02 By Nasdaq GlobeNewswire

iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

06 Jan 2021 16:01:00 By Nasdaq GlobeNewswire